earnings
confidence high
sentiment negative
materiality 0.55
10x Genomics reports preliminary Q4 2024 revenue of $165M, down 10% YoY but up 9% sequentially
10x Genomics, Inc.
2024-FY EPS reported
-$1.52
revenue$610,785,000
- FY2024 revenue ~$610.8M (-1% YoY); Q4 revenue ~$165M (-10% YoY, +9% sequentially).
- Instruments Q4 revenue $24.4M (-37% YoY); consumables $133.5M (-5% YoY); services $7.1M (+35% YoY).
- Cumulative instruments deployed >7,000; cash and equivalents ~$393M.
- Preliminary and unaudited; subject to adjustment after year-end close.